Publications

The Changing Face of Oxacillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A SENTRY Report, 1998 -2007, Lead author: Turnidge JD, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of Vancomycin (VAN) Potency Trends (&quotCreep&quot) Against Methicillin-Resistant S. aureus Collected in Nine United States Hospitals Over Five Years (2002- 2006), Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Susceptibility of Clinical Strains of KPC-Producing and CTX-M-Producing Enterobacteriaceae: A Global Analysis, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Acquired Carbapenem Hydrolyzing ß-Lactamases Among Clinical Strains of Acinetobacter spp. from Latin America: Report from the SENTRY Antimicrobial Program, Lead author: Gales AC, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Rapid Emergence and Spread of Acinetobacter spp. (ASP) Producing Carbapenem-Hydrolyzing Oxacillinases (CHCDß): Report from the SENTRY Program, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Outbreak Caused by a Clone of OXA-23- or OXA-58-Producing Acinetobacter baumannii (ACB) in a Rome Hospital: First Outbreak of bla_OXA-23-Carrying ACB in Italy, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Coproduction of OXA-58 and IMP-1 Carbapenemases in an Acinetobacter lwoffii (AL), Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Tigecycline Tested against Acinetobacter spp. Producing Carbapenem-Hydrolyzing Oxacillinases: a Global Study of 320 Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

An Extended Aminoglycoside Resistance Profile in Isolates of Enterobacteriaceae from the Sentry Surveillance Program in the Asia-Pacific Region, 2007, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Enterobacter Species as a Major Reservoir for Extended-Spectrum ß-lactamase Encoding and Related Genes in the Sentry Asia-Pacific Region 2006, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Comparison of Broth Microdilution and Etest Method Results when Testing Vancomycin (VAN) and Daptomycin (DAP) Against Methicillin-Resistant S. aureus (MRSA) from 9 USA Hospitals, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of the Accuracy of the Etest Macromethod for Detection of Heterogeneous Vancomycin-Intermediate S. aureus (hVISA) Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Gram-Negative and Gram-Positive Organisms vs. Doxycycline, Lead author: Killian SB, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Acinetobacter spp., Pseudomonas spp. and Pseudomonas aeruginosa vs. Colistin(COL) and Polymixin B (POL), Lead author: Holliday, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Rhomberg PR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Tigecycline In Vitro Susceptibility Test Accuracy Using Three Methods and USA-FDA Interpretive Criteria When Testing Japanese Clinical Isolates (2007), Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

TR-700, a Novel Oxazolidinone, Tested Against Linezolid-Resistant Gram-positive Species with Well-Characterized Resistance Mechanisms, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species, Lead author: Sutcliffe, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Nanoemulsions Tested Against Seven Gram-Negative Species, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101 Activity Against 331 Respiratory Tract Pathogens Including Multidrug-Resistant Pneumococcal Serogroup 19A (MDR-19A) Isolates, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Potential Application Against Species Causing Enteritis/Gastroenteritis, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: PAE, Bactericidal Activity and Combinations, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Single Step, Selection by Passaging and Inducible Resistances, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Assessment of CEM-101 Susceptibility Testing Conditions and Optimization of Disk Diffusion Methods, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed Quality Control (QC) Parameters for Disk Diffusion (DD) Tests with Anidulafungin, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance, Lead author: Diekema DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Anidulafungin and Other Antifungal Agents: Results from an International Fungal Surveillance Program (2006-2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Daptomycin Tested against Gram-positive Clinical Strains with Acquired Resistance to Linezolid, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Multicenter Retrospective Evaluation of Tigecycline Tested Against Clinical Pathogens from Japan (2003-2004), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

OXA- and MBL-Type Enzymes Among Uncommonly Isolated Acinetobacter Spp. in Asia-Pacific Nations: Natural Reservoir for Resistance Determinants, Lead author: Mendes RE, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Comparative in Vitro Activity of Zabofloxacin (DW-224a) Tested Against Multidrug-Resistant Neisseria gonorrhoeae, Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Activity Tested Against a Contemporary Collection of Gram-positive Bacteria from Hospitals in the UK and Ireland: Results from DECIDE Program, Lead author: Cormican, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin and Selected Comparison Agents Tested Against Indicated Gram-positive Isolates in European Medical Centers (Italy): Results from the DECIDE Program, Lead author: Debbia, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Comparative Activity Tested Against Gram-positive Species in German Medical Centers: Results from the DECIDE Program, Lead author: Just-Nuebling, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Telavancin Against Contemporary Streptococcus spp. Pathogens: Recent Results from a European Surveillance Program (2007), Lead author: Fritsche TR, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Daptomycin Tested Against Multidrug-Resistant Gram-Positive Strains Collected in European Hospitals (2003-2007), Lead author: Sader HS, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand, Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006), Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline Activity in India: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens from Japan (2006-2007), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Tested Against Staphylococcus spp. and Streptococcus spp. Isolates collected from Five European Counties: Comprehensive DECIDE Program Results (2007), Lead author: Biedenbach DJ, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006), Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Tigecycline Activity against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report, Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006), Lead author: Bell JM, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multi-Center Surveillance Results (3,617 strains) Comparing the Gram-Positive Activity of Dalbavancin in the United States and Europe During 2005-2007, Lead author: Biedenbach DJ, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Comparative Activity of Meropenem and Other Broad-Spectrum Antimicrobials: Resistance Surveillance Testing Results from the USA MYSTIC Program (2007), Lead author: Rhomberg PR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program 2007: Assessing Oxazolidinone and Inducible Clindamycin Resistance, Lead author: Ross JE, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Antimicrobial Activity of Doripenem Against Leading Bacterial Pathogens: Results from a Latin American Surveillance Study (2003-2006), Lead author: Gales AC, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Regression Analysis of MIC Versus Disk Diffusion Zone Diameters for Three Carbapenems Tested against Enterobacteriaceae Isolates Harboring Serine Carbapenemases with Matched Control Strains, Lead author: Fritsche TR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA